Muscarinic acetylcholine M1 receptor antagonists
US12390462B2 · kind B2 · utility
0Cited by
19References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2023 |
| Grant date | Aug 19, 2025 |
| Priority date | — |
| Expiry date | Sep 30, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.